Skip to main content

About Us

What's this site about?

Big Pharma Watchdog was created out of concern over the pharmaceutical industry. As drug companies become more powerful, they are able to rush-to-market various products. Even though these all have to go through FDA approval, oversights and mistakes happen.

Sometimes this results in someone dying.

Big Pharma Watchdog hopes to prevent this.

Where do we get our information?

Thankfully the FDA is watching the pharmaceutical and medical device industries. Whenever there's a problem with a drug or device, the FDA releases a press release. Unfortunately, these press releases are written in technical jargon and for medical experts. That means average people, like you and I, can have a hard time understanding these warnings.

Big Pharma Watchdog is our attempt to take certain FDA press releases and translate them into everyday language. This way anyone can understand the risks and dangers from some of these products.

Of course, don't take our word for it. If you find that you, or a loved-one, has used any of these products please:

  1. Call your doctor. They are the true medical expert- not us. Our hope is that these articles allow you to better understand what might have gone wrong so you can seek proper medical advice.
  2. Get a second opinion. Your doctor might be hesitant to give you the full picture. Perhaps they might be afraid of a lawsuit. Another doctor might be able to help you understand what's going on and what you can do about it.
  3. Call a lawyer. Some doctors might not give you the full picture. As long as you are out of immediate medical danger, call your lawyer and ask for advice. They might be able to review your case, as well as your medical records, and offer productive advice in your time of need. 


Who is publishing this?

David Zimmerman is an internet marketing expert, by trade. He is not a doctor or lawyer (to the disappointment of his mother). He is applying his skills with internet marketing with the hopes of making these FDA notices more accessible to average people- who might have suffered from one of these products. Don't believe him. Call your doctor or lawyer, if you need to understand what might have happened to you, or your loved-one, after using one of these products.

Popular posts from this blog

News About Phenobarbital Tablets by C.O.Truxton

Do you own a bottle of Phenobarbital Tablets by C.O. Truxton, Inc.?   Maybe you, or someone you know, has been prescribed phenobarbital tablets for sleep, or to control convulsions or seizures.

C.O. Truxton, Inc., has recalled Phenobarbital Tablets, 15mg, because someone who bought a bottle of this medication discovered the label had been placed in error on a bottle of this medication with a different dosage strength. The bottle labeled 15mg tablets was actually 30mg tablets. This mistake on the label could potentially cause someone to accidentally take an overdose of phenobarbital.

If you take an overdose of phenobarbital, it can cause:

your heart to beat too fast your breathing to be too rapid  you to become pale, weak, and sweat heavily  you to become unconscious  your kidneys to fail, leading to reduced urine, swelling of legs and feet, possibly confusion, shortness of breath you to fall into a coma you to need life-saving emergency treatment 

Even though only one mislabeled bottle…

News About Codeine and Tramadol Restrictions for Children

Earlier this year, the Food and Drug Administration warned parents against giving their young ones prescription drugs with codeine and tramadol. The agency said that the drugs could lead to severe breathing problems among the children and even death.

Codeine is indicated as a suitable drug for pain and cough while Tramadol heals pain. Codeine is also used as a cough syrup for toddlers and cold remedies. Manufactured by Par Pharmaceuticals, codeine is a generic medicine which is associated with various brands. It is usually marketed as a single ingredient drug or in combination preparations with paracetamol, aspirin, and ibuprofen.  The various combinations also pose a greater risk to children aged 12 years and below and among adolescents aged 18 years and below.  The drug is also marketed in products containing muscle relaxers. Healthcare providers are discouraged from prescribing the drug to adolescents aged between 12  and 18 years who are obese or show any other conditions that may…

Infant/Child Reduced Energy Defibrillation Electrodes News

The US Food and Drug Administration recently announced a voluntary field action on the Infant/Child Reduced Energy Defibrillation Electrodes, citing possible defects in the product. The voluntary field action for the product was carried out by Physio-Control, one of the leading defibrillator manufacturers in the country, although the product in question was manufactured by Cardinal Health. The FDA has since classified the voluntary field action as a Class 1 recall based on the artwork depiction of incorrect placement of defibrillation electrodes.

The FDA went further to state that these defibrillation electrodes, manufactured by Cardinal Health, don’t have any functional or performance defects. The only problem with these defibrillation electrodes is in their packaging, where the manufacturer displays the incorrect electrode placement on the infant’s body. These defibrillation electrodes are part of the components of Cardinal Health’s Lifepak automated external defibrillators.

The pur…